We manufacture wide range of dosage forms complying to USFDA standard.
SOLID ORAL DOSAGE FORMS (TABLETS, CAPSULES, POWDERS, SACHETS, PELLETS AND BEADS) PARENTERAL DOSAGE FORMS (LIQUID AND LYOPHILIZED POWDERS) COMPLEX GENERICS (MODIFIED RELEASE, BILAYER, MUPS AND OCAS) 
Our manufacturing facilities in Bandar Enstek offer robust business connectivity to the regional market due to the location of less than 5km away from Kuala Lumpur International Airport (KLIA).
Spread across more than 12 acres of land, the facilities are designed by internationally renowned European pharma engineering firm to meet strict regulatory requirement of USFDA, EMA, PIC/S and WHO.
Synergy is a finished products manufacturing facility based in Bandar Enstek, Negeri Sembilan. The state-of-the-art manufacturing facility is the FIRST in Malaysia with cutting-edge technology for palletisation, Bilayer and MUPS.
"
Celsus is the FIRST fully-automated, high-containment (OEB5) Finished Products manufacturing plant in South-East Asia. Annually, Celsus has the capacity to produce 650Mn+ tablets & capsules.
Located in the heart of Uzbekistan's capital city of Tashkent, SYNERGY II was acquired as part of a long-term vision to Novugen's global presence. The facility has a capacity to cater to the whole CIS region and other neighbouring countries.
CELSUS II is the FIRST Oncology Finished Products manufacturing plant in Pakistan.
Our obsession for quality drives the company to achieve the highest standards for our products and services. This is aligned with our strategy and business philosophy to comply to USFDA and EU requirements through our day-to-day operations.
Our regulations and compliance systems assure pre-qualification of material vendors. We operate with stringent in-process system that provide control over any changes and documentation.
